GPT-Rosalind (OpenAI) vs Arcee Trinity-Large-Thinking

Which one should you pick? Here's the full breakdown.

GPT-Rosalind (OpenAI)

C
6.8/10

OpenAI's first domain-specific model -- life sciences, drug discovery, translational medicine. Launched 2026-04-16 as a Trusted Access research preview. Launch partners: Amgen, Moderna, Allen Institute, Thermo Fisher. Paired with a Life Sciences Codex plugin (50+ scientific tool integrations)

Our Pick

Arcee Trinity-Large-Thinking

A
8.1/10

Arcee AI's US-made open-weight frontier reasoning model -- launched 2026-04-01. 398B total params, ~13B active. Sparse MoE (256 experts, 4 active = 1.56% routing). Apache 2.0, trained from scratch. #2 on PinchBench trailing only Claude 3.5 Opus. ~96% cheaper than Opus-4.6 on agentic tasks

CategoryGPT-Rosalind (OpenAI)Arcee Trinity-Large-Thinking
Ease of Use3.06.0
Output Quality9.09.0
Value7.09.5
Features8.08.0
Overall6.88.1

Pricing Comparison

FeatureGPT-Rosalind (OpenAI)Arcee Trinity-Large-Thinking
Free TierNoYes
Starting PriceInvite only$0

Which Should You Pick?

Pick GPT-Rosalind (OpenAI) if...

Researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get Trusted Access. Also relevant to anyone building life-sciences AI products who needs to understand where OpenAI's vertical strategy is heading.

Visit GPT-Rosalind (OpenAI)

Pick Arcee Trinity-Large-Thinking if...

  • Easier to use (6 vs 3)
  • Better value for money (9.5/10)
  • Has a free tier

Teams that need a US-made, Apache 2.0, frontier-tier open-weight model and can either rent multi-GPU infrastructure or pay OpenRouter API pricing at ~$0.90/M output tokens. Particularly valuable for US government, defense, or regulated enterprise contexts where country-of-origin matters for procurement. Also good for agentic reasoning workloads where the ~96% cost savings vs Claude Opus actually changes what you can build.

Visit Arcee Trinity-Large-Thinking

Our Verdict

Arcee Trinity-Large-Thinking is the clear winner here with 8.1/10 vs 6.8/10. GPT-Rosalind (OpenAI) isn't bad, but Arcee Trinity-Large-Thinking outperforms it across the board. Pick GPT-Rosalind (OpenAI) only if researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get trusted access.